Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

AstraZeneca to Double Stock Buyback as New Drugs Have Setbacks
Bloomberg
Thu, 01/27/11 - 08:52 am
Tags:
stock buyback, AstraZeneca
Decent Quarter for Dr. Reddy's
Yahoo/Zacks.com
Wed, 01/26/11 - 10:47 am
Tags:
Dr Reddy's, earnings, AstraZeneca
INTERVIEW: AstraZeneca R&D Chief Seeks Alliances, In-Licensing
WSJ Online
Mon, 01/24/11 - 12:49 pm
Tags:
AstraZeneca, R&D, in-licensing
Showdown time is coming for AZ's Crestor
Fierce Pharma
Fri, 01/21/11 - 10:15 am
Tags:
AstraZeneca, Crestor, patents, generics
AstraZeneca Replies to FDA’s Decision on Brilinta
Bloomberg
Fri, 01/21/11 - 07:55 am
Tags:
Brilinta, FDA, AstraZeneca, blood thinners
Targacept drug trial shows promise
Bizjournals.com
Thu, 01/20/11 - 01:44 pm
Tags:
Targacept, schizophrenia, AstraZeneca, TC-5619
PDL shares rise on analyst upgrade
Yahoo/AP
Thu, 01/20/11 - 11:18 am
Tags:
PDL Biopharma, AstraZeneca, upgrades
Forest Labs Has Wood To Chop
Investopedia
Wed, 01/19/11 - 11:12 am
Tags:
Forest Labs, AstraZeneca, GSK, Merck, Novartis, Pfizer
Bayer Among Drug Firms in EU Probe of Patent Deals
Bloomberg Businessweek
Mon, 01/17/11 - 01:05 pm
Tags:
patents, Europe, Bayer, AstraZeneca, Nycomed
Just One Stock: The Healthcare Giant With a Low Multiple and Solid Yield
Seeking Alpha
Fri, 01/14/11 - 09:47 am
Tags:
Abbott Laboratories, AstraZeneca, Bayer, JNJ, Eli Lilly, Pfizer
Here's How Genzyme May Be Failing You
Motley Fool
Tue, 01/11/11 - 02:35 pm
Tags:
Genzyme, Novartis, AstraZeneca, GSK
A Biotech Roller Coaster
Motley Fool
Sat, 01/8/11 - 11:57 am
Tags:
Lexicon Pharmaceuticals, diabetes, LX4211, Merck, obesity, Amylin, Januvia, Onglyza, Bristol-Myers Squibb, AstraZeneca
AstraZeneca: FDA Extends Vandetanib NDA Review Timeline To April 7
WSJ Online
Fri, 01/7/11 - 10:07 am
Tags:
FDA, NDA, vandetanib, AstraZeneca
This NICE Deal Could Foreshadow 2011
Motley Fool
Fri, 12/31/10 - 10:55 am
Tags:
NICE, GSK, Pfizer, Human Genome Sciences, Bristol-Myers Squibb, Merck, AstraZeneca, value-based pricing
The Painful Death of a Promising Drug Class
Motley Fool
Thu, 12/30/10 - 10:53 am
Tags:
Regeneron, Sanofi, JNJ, AstraZeneca, NGF-1
The Most Promising Dividends in Pharmaceuticals
Motley Fool
Wed, 12/29/10 - 11:48 am
Tags:
dividends, Eli Lilly, GSK, Bristol-Myers Squibb, Pfizer, Merck, Abbott Laboratories, JNJ, Merdian, Sanofi, Novartis, AstraZeneca, Teva Pharmaceuticals, Novo Nordisk
Abbott the Only One Left in the Osteoarthritis Game
Seeking Alpha
Wed, 12/29/10 - 11:28 am
Tags:
Abbott Laboratories, osteoarthritis, JNJ, AstraZeneca, Pfizer, Regeneron, Sanofi
AstraZeneca's Brennan Poaches Pfizer to Rebuild Research
Bloomberg
Wed, 12/29/10 - 10:47 am
Tags:
Pfizer, R&D, AstraZeneca, David Brennan, Pharma CEOs
J&J, AstraZeneca Halt Experimental Pain Drug Tests on Bone-Damage Concern
Bloomberg
Tue, 12/28/10 - 10:56 am
Tags:
JNJ, AstraZeneca
Deals to Be Done After AstraZeneca Setback
WSJ Online
Thu, 12/23/10 - 08:26 am
Tags:
AstraZeneca, RSV, Cubist Pharmaceuticals, NanoBio, MicroDose Therapeutx, Novavax, Synagis, motavizumab, Alnylam

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.